Detection Sensitivity of Ultrasound Scanning vs. Clinical Examination for Insulin Injection-Related Lipohypertrophy
Lipohypertrophy (LH) is the most prevalent local complication arising from repeated insulin injections, characterized histologically by subcutaneous tissue changes such as reduced vascularity, fibrosis, and adipocyte enlargement. Clinically, LH manifests as thickened or lump-like tissue at injection sites. These lesions disrupt insulin absorption, leading to unpredictable glycemic control and increased risks of hypoglycemia or hyperglycemia. Despite its clinical significance, the optimal diagnostic approach for LH remains debated. Current methods include clinical examination (inspection and palpation) and ultrasound scanning (USS), but limited large-scale studies have compared their detection accuracy. This study evaluates the sensitivity and specificity of USS versus clinical examination in diagnosing LH and identifies factors contributing to discrepancies between the two methods.
Study Design and Participants
A cross-sectional analysis was conducted at the National Endocrine and Metabolism Centre in Jiangsu, China, involving 382 patients undergoing daily insulin therapy with abdominal injections. Inclusion criteria required participants to be >10 years old, diagnosed with type 1 or type 2 diabetes per WHO 1999 criteria, and using abdominal insulin injections or pumps for ≥1 year. Exclusion criteria included glucagon-like peptide-1 agonist use or dermatological conditions affecting the abdomen. Patients underwent structured interviews to collect demographic (age, sex, education) and clinical data (diabetes duration, insulin exposure duration, BMI, injection tools, needle reuse frequency, and insulin doses).
Diagnostic Methods
Two blinded evaluators independently assessed LH using clinical examination and USS. Clinical examination involved visual inspection and manual palpation to detect skin thickening, nodules, or abnormal tissue texture. USS employed high-frequency linear probes (7–12 MHz) to identify LH through sonographic features: hypoechoic areas, loss of normal fat lobulation, and fibrosis. LH was classified as “present” or “absent” using both methods.
Key Findings
Among 382 participants, USS detected LH in 87.2% (333/382), while clinical examination identified LH in 73.0% (279/382). Discordant results occurred in 86 cases (22.5%): USS missed LH in 16 patients diagnosed via clinical examination, whereas clinical examination failed to detect LH in 70 USS-positive cases. Statistical analysis revealed significant disagreement between methods (McNemar’s χ² = 16.000, P < 0.001), with only fair agreement (Cohen’s κ = 0.315, P < 0.001).
Sensitivity and Specificity
Using clinical examination as the reference standard, USS demonstrated 94.3% sensitivity but low specificity (32.0%). Conversely, when USS was the reference, clinical examination showed 79.0% sensitivity and 67.3% specificity. USS’s higher sensitivity makes it superior for minimizing false negatives, while clinical examination’s specificity reduces false positives.
Influencing Factors for Discrepancies
Binary logistic regression identified three independent predictors of discordant LH detection:
- Insulin Exposure Duration: Shorter insulin therapy duration correlated with higher inconsistency rates (OR = 0.860, 95% CI: 0.80–0.93, P < 0.001). Early-stage LH may lack palpable features, making clinical examination less reliable.
- BMI: Overweight (BMI 25.0–29.9 kg/m²; OR = 1.36, P = 0.032) and obese (BMI ≥30.0 kg/m²; OR = 2.81, P = 0.036) patients had higher discordance rates. Thicker subcutaneous fat in these groups likely obscured palpation of early LH lesions.
- Needle Reuse Frequency: Although not significant in multivariate analysis, frequent needle reuse trended toward inconsistency in univariate testing, possibly due to increased tissue trauma accelerating LH development.
Clinical and Technical Implications
The study highlights the complementary roles of USS and clinical examination. USS excels in early LH detection, particularly in overweight populations and those with shorter insulin exposure, where lesions may not yet be palpable. However, its lower specificity necessitates confirmatory clinical assessment to avoid overdiagnosis. Conversely, clinical examination, while less sensitive, offers rapid, cost-effective screening suitable for resource-limited settings.
Notably, subclinical LH (USS-positive but clinically undetected) is linked to poor glycemic control, emphasizing the need for early identification. Proactive management, including patient education on injection site rotation and needle replacement, can mitigate LH progression.
Limitations and Future Directions
The study’s focus on abdominal injections limits generalizability to other injection sites (e.g., thighs or arms). Additionally, the absence of a histological gold standard precludes definitive accuracy comparisons. Future research should validate USS against histopathology and explore automated imaging tools to standardize LH diagnosis.
Conclusion
USS and clinical examination each have distinct advantages in LH detection. For comprehensive assessment, combining both methods is recommended, particularly in high-risk groups such as obese patients or those with recent insulin initiation. Clinicians should prioritize USS for patients with unexplained glycemic variability or higher BMI, while reserving clinical examination for routine monitoring. This dual approach ensures timely intervention, optimizing diabetes management and reducing long-term complications.
doi.org/10.1097/CM9.0000000000001742
Was this helpful?
0 / 0